Chief Physician, Master's Supervisor. Specializes in soft‑tissue sarcoma, malignant bone tumors, pancreatic malignant tumors, neuroendocrine tumors, as well as targeted therapy and immunotherapy for solid tumors. He has extensive clinical experience in bone and soft‑tissue sarcomas, pancreatic malignant tumors and neuroendocrine tumors. He has participated in the formulation and compilation of multiple CSCO guidelines, including the Guidelines for the Diagnosis and Treatment of Soft‑Tissue Sarcoma, Guidelines for the Diagnosis and Treatment of Giant Cell Tumor of Bone, Guidelines for the Diagnosis and Treatment of Pancreatic Cancer, and Guidelines for the Diagnosis and Treatment of Neuroendocrine Tumors, and has taken part in drafting several domestic expert consensus statements. He has participated in more than ten research and clinical trial projects for various novel adoptive cell therapy technologies, and boasts rich experience in tumor immunotherapy and biotherapy. He is the lead translator for published monographs such as Diagnosis and Treatment of Soft‑Tissue Sarcoma, Diagnosis and Treatment of Bone Sarcoma, Molecular Testing for Cancer, and Gastrointestinal Stromal Tumors: From Bench to Bedside. He is the recipient of the Second‑Class Award of Shanghai Medical Science and Technology Award and the honorary title of "National Renowned Doctor · Distinguished Demeanor".